bioAffinity Technologies, Inc.
BIAF
$1.60
$0.031.59%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 13.91% | -31.51% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.91% | -31.51% | |||
| Cost of Revenue | -7.32% | -25.68% | |||
| Gross Profit | 99.25% | -47.93% | |||
| SG&A Expenses | -0.23% | -9.70% | |||
| Depreciation & Amortization | 0.18% | -26.78% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.22% | -15.53% | |||
| Operating Income | 8.86% | 4.24% | |||
| Income Before Tax | -25.20% | -52.05% | |||
| Income Tax Expenses | -88.97% | 233.33% | |||
| Earnings from Continuing Operations | -24.39% | -52.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -24.39% | -52.64% | |||
| EBIT | 8.86% | 4.24% | |||
| EBITDA | 5.49% | 10.23% | |||
| EPS Basic | 6.60% | -3.30% | |||
| Normalized Basic EPS | 5.99% | -2.90% | |||
| EPS Diluted | 6.60% | -3.30% | |||
| Normalized Diluted EPS | 5.99% | -2.90% | |||
| Average Basic Shares Outstanding | 33.18% | 47.76% | |||
| Average Diluted Shares Outstanding | 33.18% | 47.76% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||